Synapse - Valerie Rusch

Search Within

Valerie W Rusch

Results (869)

A cancer staging primer: Esophagus and esophagogastric junction

Journal Article

Rice, T. W.; Blackstone, E. H.; Rusch, V. W.
Journal of Thoracic and Cardiovascular Surgery (2010)

Soluble mesothelin related peptides (SMRP) and osteopontin as protein biomarkers for malignant mesothelioma: Analytical validation of ELISA based assays and characterization at mRNA and protein levels

Journal Article

Rai, A. J.; Flores, R. M.; Mathew, A.; Gonzalez-Espinoza, R.; Bott, M.; Ladanyi, M.; Rusch, V.; Fleisher, M.
Clinical Chemistry and Laboratory Medicine (2010)

Fulltext@MSK | Save

Assessment of therapy responses and prediction of survival in malignant pleural mesothelioma through computer-aided volumetric measurement on computed tomography scans

Journal Article

Liu, F.; Zhao, B.; Krug, L. M.; Ishill, N. M.; Lim, R. C.; Guo, P.; Gorski, M.; Flores, R.; Moskowitz, C. S.; Rusch, V. W.; more...
Journal of Thoracic Oncology (2010)

Fulltext@MSK | Save

Insulin-like growth factor-1 receptor expression in thymic malignancies

Journal Article

Girard, N.; Teruya-Feldstein, J.; Payabyab, E. C.; Riely, G. J.; Rusch, V. W.; Kris, M. G.; Zakowski, M. F.
Journal of Thoracic Oncology (2010)

Fulltext@MSK | Save

Use of epidermal growth factor receptor/kirsten rat sarcoma 2 viral oncogene homolog mutation testing to define clonal relationships among multiple lung adenocarcinomas: Comparison with clinical guidelines

Journal Article

Girard, N.; Deshpande, C.; Azzoli, C. G.; Rusch, V. W.; Travis, W. D.; Ladanyi, M.; Pao, W.
Chest (2010)

Fulltext@MSK | Save

Predictors of outcomes after surgical treatment of synchronous primary lung cancers

Journal Article

Finley, D. J.; Yoshizawa, A.; Travis, W.; Zhou, Q.; Seshan, V. E.; Bains, M. S.; Flores, R. M.; Rizk, N.; Rusch, V. W.; Park, B. J.
Journal of Thoracic Oncology (2010)

Fulltext@MSK | Save

Phase II study of induction and adjuvant bevacizumab in patients with stage IB-IIIA non-small cell lung cancer (NSCLC) receiving induction docetaxel and cisplatin

Meeting Abstract

Price, K.; Kris, M. G.; Rusch, V.; Finley, D. J.; Azzoli, C. G.; Downey, R. J.; Bains, M. S.; Miller, V. A.; Rizk, N.; Rizvi, N. A.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Phase II trial of preoperative bevacizumab (Bev), irinotecan (I), cisplatin (C), and radiation (RT) in esophageal adenocarcinoma: Preliminary safety analysis

Meeting Abstract

Ilson, D.; Bains, M.; Rizk, N.; Rusch, V.; Flores, R.; Park, B.; Shah, M.; Kelsen, D.; Miron, B.; Goodman, K.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Operative outcomes using bevacizumab, docetaxel, and cisplatin as induction therapy in patients with operable lung cancer

Meeting Abstract

Finley, D. J.; Shen, R.; Rizvi, N. A.; Rusch, V. W.; Kris, M. G.; on behalf of the MSKCC Thoracic Disease Management Team
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Frequency of use and outcome of surgical resection in the management of malignant mesothelioma in a community-based population: Results in 5,937 patients

Meeting Abstract

Flores, R. M.; Riedel, E.; Donington, J. S.; Krug, L.; Rosenzweig, K.; Adusumilli, P.; Carbone, M.; Rusch, V. W.; Pass, H. I.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save